XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Income - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2022
Nov. 30, 2021
Income Statement [Abstract]        
Net Sales $ 3,586,165 $ 4,419,401 $ 11,401,029 $ 12,134,336
Cost of Goods Sold 1,761,797 2,260,874 5,574,035 6,077,645
Gross Profit 1,824,368 2,158,527 5,826,994 6,056,691
Operating Expenses        
Research and product development costs 520,187 417,300 1,543,310 1,243,513
Marketing and selling expenses 792,710 845,362 2,359,430 2,349,607
General and administrative costs 407,990 405,280 1,262,670 1,181,502
Total Operating Expenses 1,720,887 1,667,942 5,165,410 4,774,622
Operating Income 103,481 490,585 661,584 1,282,069
Interest and Dividend Income 38,803 2,367 64,725 13,367
Net unrealized loss on marketable securities (9,231) (40,256)
Paycheck Protection Program Loan Forgiveness 1,005,372
Income Before Income Taxes 133,053 492,952 686,053 2,300,808
 Income Tax Expense 28,155 116,783 113,396 314,063
Net Income $ 104,898 $ 376,169 $ 572,657 $ 1,986,745
Basic Earnings Per Share $ 0.01 $ 0.02 $ 0.04 $ 0.13
Diluted Earnings Per Share $ 0.01 $ 0.02 $ 0.04 $ 0.13
 Weighted Average Shares - Basic 15,738,180 15,622,721 15,733,284 15,541,247
Weighted Average Shares - Diluted 15,773,370 15,654,936 15,764,351 15,572,424